Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+14574Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+24360Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+34885Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+39932Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+96016Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+106379Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+119371Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+123177Peak areaPAK Untreated
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+141051Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+187510Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+194091Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+207632Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+211668Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+241966Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODENICOTINAMIDE (CAS# 98-92-0); (M+H)+422140Peak areaBS4 IFN-G

Return to search page
  logo